<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Genes &amp; Cells</journal-id><journal-title-group><journal-title xml:lang="en">Genes &amp; Cells</journal-title><trans-title-group xml:lang="ru"><trans-title>Гены и Клетки</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Genes and Cells</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-1829</issn><issn publication-format="electronic">2500-2562</issn><publisher><publisher-name xml:lang="en">Human Stem Cells Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">182586</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Reviews</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Научные обзоры</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Resident Cardiomyocyte Precursors and Myocardium Regeneration</article-title><trans-title-group xml:lang="ru"><trans-title>Резидентные клетки-предшественники в сердце и регенерация миокарда</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Rubina</surname><given-names>K. A.</given-names></name><name xml:lang="ru"><surname>Рубина</surname><given-names>К. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>zv20@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Melikhova</surname><given-names>V. S.</given-names></name><name xml:lang="ru"><surname>Мелихова</surname><given-names>В. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>redaktor@celltranspl.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Parfenova</surname><given-names>E. V.</given-names></name><name xml:lang="ru"><surname>Парфенова</surname><given-names>Е. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>redaktor@celltranspl.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Moscow State University, Faculty of Medicine</institution></aff><aff><institution xml:lang="ru">Факультет фундаментальной медицины МГУ им. Ломоносова</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Russian Cardiology Research and Production Center</institution></aff><aff><institution xml:lang="ru">Российский кардиологический научно-производственный комплекс</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Institute of Experimental Cardiology</institution></aff><aff><institution xml:lang="ru">Институт экспериментальной кардиологии</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">«Gene and Cellular Therapy» Ltd</institution></aff><aff><institution xml:lang="ru">ООО «Генная и клеточная терапия»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2007-03-15" publication-format="electronic"><day>15</day><month>03</month><year>2007</year></pub-date><volume>2</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>29</fpage><lpage>35</lpage><history><date date-type="received" iso-8601-date="2023-02-03"><day>03</day><month>02</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-02-03"><day>03</day><month>02</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2007, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2007, Эко-Вектор</copyright-statement><copyright-year>2007</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://genescells.ru/2313-1829/article/view/182586">https://genescells.ru/2313-1829/article/view/182586</self-uri><abstract xml:lang="en"><p>The review represents development of different views on the potential of cardial muscle tissue regeneration as well as up-to-date data on existence and functioning of resident precursors of cardiomyocytes.</p></abstract><trans-abstract xml:lang="ru"><p>В обзоре представлена история развития взглядов на возможности регенерации сердечной мышечной ткани. Обсуждены современные данные о существовании и функционировании резидентных клеток-предшественников кардиомиоцитов.</p></trans-abstract><kwd-group xml:lang="en"><kwd>heart</kwd><kwd>myocardium</kwd><kwd>cardiac stem cells</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>сердце</kwd><kwd>миокард</kwd><kwd>стволовые клетки сердца</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Cleland J.F.G., McGowan J. Heart Failure due to Ischaemic Heart Disease: Epidemiology, Pathophysiology and Progression. J Cardiovasc Pharmacol 1999; 33(suppl. 3):S17-S29.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Kim W.H., Joo C.U., Ku J.H. et al. Cell cycle regulators during human atrial development. Korean J Intern Med 1998; 13(2):77-82.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Orlic D., Kajstura J., Chimenti S., et al. Mobilized bone marrow repair the infracted heart, improving function and survival. PNAS 2001; 98: 10344-10349.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Friedenstein A.J., Gorskaja J.F., Kulagina N.N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976; 4: 267274.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Koh G.Y., Soonpaa M.H., Klug M.G., et al. Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs. J Clin Invest 1995; 96(4):2034-42.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Leor J., Patterson M., Qumones M.J. et al. Transplantation of Fetal Myocardial Tissue Into the Infarcted Myocardium of Rat A Potential Method for Repair of Infarcted Myocardium? Circulation 1996; 94: 332-336.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Li R.K., Mickle D.A.G., Weisel R.D. et al. Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation 1997; 96:179-187.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Fernandes K. J. L., McKenzie I. A., Mill P., Smith K. M., Akhavan M., Barnabé-Heider F. A dermal niche for multipotent adult skin-derived precursor cells. Nat Cell Biol 2004; 6: 1082 Œ 1093.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Quaini F., Urbanek K., Beltrami A.P., Finato N., Beltrami C.A., Nadal-Ginard B., Kajstura J., Leri A., Anversa P. Chimerism of the transplanted heart. N. Engl. J. Med. 2002; 346: 5-15.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Muller A., Pfeiffer P., Koglin J., Schflfers H-J., Seeland U., et al. Cardiomyocytes of non-cardiac origin in myocardial biopsies of human transplanted hearts. Circulation 2002; 106 : 31-35.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Strauer B.E., Brehm M., Zeus T., Kqstering M., Hernandez A., et al. Repair of infracted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106: 1913-1918.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Wollert K.C., Lotz M. J., Lichtenberg S. R., Lippolt P., Breidenbach C., Fichtner S., Korte T., Hornig B., Messinger D. Intracoronary autologous bonemarrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004; 364: 141-148.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Katritsis D.G., Sotiropoulou P.A., Karvouni E. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infracted human myocardium. Catheter Cardiovasc Interv 2005; 65: 321329.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Archundia A., Aceves J.L.,Lopez-Hernandez M., et al. Direct cardiac injection of G-CSF mobilized bone-marrow stem-cells improves ventricular function in old myocardial infarction. Life Sci 2005; 78: 279-283.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Stamm C., Westphal B., Kleine H.D., Petzsch M., Kittner C., et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003; 361: 45-46.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Bartunek J., Vanderheyden M., Vandekerckhove B., et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circ 2005; 112: I178-I183.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Watanabe C. Intracoronary adipose tissue derived stem cell therapy preserves left ventricular function in a porcine infarct model. Paper presented at Transvascular Cardiovascular Therapeutics Annual Meeting, September 2004, Washington DC, USA.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Schächinger V., Tonn T., Dimmeler S., et al. Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial. Nat Clin Prac Cardiovasc Med 2006; 3 (1): 23-28.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Menasche P., Hagege A. A., Vilquin J.T., Desnos M., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003; 41:1078-83.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Erbs S. Linke A., Adams V.,et al.. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo controlled study. Circ Res 2005; 97: 756-762.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Tirziu D., Simons M. Angiogenesis in the human heart: gene and cell therapy. Angiogenesis. 2005;8(3): 241-51.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Ripa R.S., Jorgensen E., Wang Y., et al. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the doubleblind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation2006; 113: 1983-1992.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Askari A.T., Unzek S., Popovic Z.B., et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2004; 362 : 697-703.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Okada H., Takenura G., Kosai K., et al. Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure. Circ 2005; 111:24302437.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Losordo D.W. Vale P.R., Hendel R.C., Milliken C.E., Fortuin F.D. Phase x placebo-controlled, double -blind, Dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer be catheter delivery in patients with chronic myocardial ischemia. Circ 2002; 105:2012-2018.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Shintani S., Kusano K., Ii M., Iwakura A., Heyd L. et al. Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI. Nat ClinPract Cardiovasc Med 2005; 2:123-128.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Pislaru S.V., Simari R.D. Gene transfer for ischemic cardiovascular disease: is this the end of the beginning or the beginning of the end? Nat ClinPract Cardiovasc Med 2005; 2: 138-144.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Vassalli G., Bueler H., Dudler J., von Segesser L.K., Kappenberger L. Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors. Int J Cardiol 2003; 90: 229-238.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Brockes J.P., Kumar A., Velloso C.P. Regeneration as an evolutionary variable. J Anat 2001; 199: 3-11.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Poss K.D., Wilson L.G., Keating M.T. Heart regeneration in zebrafish. Science 2002; 298: 2188-2190.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Leferovich J.M. Bedelbaeva K., Samulewicz S., Zhang X.M., Zwas D. Heart regeneration in MRL mice. PNAS 2001; 98:9830-9835.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Румянцев П.П. Кардиомиоциты в процессах репродукции, дифференцировки и регенерации. Наука; 1982.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Urbanek K., Quaini F., Bolli R., Leri A., Kajstura J., Anversa P. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. PNAS 2005; 102(24):8692-7.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Varma J., Prabhu S., Anversa P.A., Bolli R. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A 2005; 102(10):3766-71.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Beltrami A.P., Urbanek K., Kajstura J., et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001; 344: 1750-1757.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Beltrami A.P. Urbanek K., Kajstura J., Yan S.M., Finato N., et al. Cardiac c-kit positive cells proliferate in vitro and generate new myocardium in vivo. Circulation 2001; 104: 324.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Oh H., Wang S. C., Prahash A., Sano M., Moravec C. S., at al. Telomere attrition and Chk2 activation in human heart failure. PNAS 2003;100:5378-5383.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Gilbert S. F. Developmental Biology. 6th ed, 2000.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Tzahor E., Lassar A. B. Wnt signals from the neural tube block ectopic cardiogenesis. Genes Dev 2001; 15:255-260.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Schultheiss T.M., Xydas S., Lassar A.B. Induction of avian cardiac myogenesis by anterior endoderm. Development 1995; 121(12):4203-14.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Andree B., Duprez D., Vorbusch B., Arnold H.H., Brand T. BMP-2 induces ectopic expression of cardiac lineage markers and interferes with somite formation in chicken embryos. Mech Dev 1998;70(1-2):119-31.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Moon R. T., Brown J. D., Torres M. WNTs modulate cell fate and behavior during vertebrate development. Trends Genet 1998; 13:157-162.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Markwald R. R., Trusk T., Moreno-Rodriguez R. Formation and septation of the tubular heart: Integrating the dynamics of morphology with emerging molecular concepts. In M. de la Cruz and R. R. Markwald (ed.), Living Morphogenesis of the Heart. Birkhauser Press, Boston; 1998.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Smadja D.M., Bieche I., Uzan G., Bompais H., Muller L., et al. PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system. Arterioscler Thromb Vasc Biol. 2005;25(11):2321-7.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Gallo P., Peschle C., Condorelli G. Sources of cardiomyocytes for stem cell therapy: an update. Pediatr Res 2006; 59(4):79R-83R.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Beltrami A.P., Barlucchi L., Torella D., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114: 763-776.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Messina E., Angelis L.D., Frati G., et al. Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart. Circ Res 2004; 95: 911-921.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Laugwitz K-L., Moretti A., Lam J., et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages, Nature 2005; 433 :647-653.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Wilson S. F., Colucci M.D., Liao R., Pfister O., Mouquet F., et al. CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res. 2005; 97:52-61.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Cesselli D., Beltrami A.P., Urbanek K., Kajstura J., et al Cardiac stem cells are nested in niches of the adult mouse heart and possess the ability to divide and differentiate in the various cardiac lineages. Circulation 2002; 106: II-14.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Urbanek K., Cesselli D., Rota M., Nascimbene A., Angelis A., HosodaT., Bearzi C., Boni A, Bolli R., Kajstura J., Anversa P., Leri A. Stem cell niches in the adult mouse heart. PNAS 2006; 103 (24): 9226-9231.</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Yoon Y.S., Wecker A., Heyd L., et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 2005; 115:326 -38.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Behfar A., Zindman L.V., Hodgson D.M., et al. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J 2002; 16: 1558-66.</mixed-citation></ref></ref-list></back></article>
